Nephron Pharmaceuticals is partnering with Clemson University to create a robotic solution for syringe-filling automation to enhance sterile manufacturing.
Nephron Pharmaceuticals Corporation, which is based in West Columbia, SC, announced on Aug. 12, 2019, that the company is partnering with Clemson University to create a robotic solution for syringe-filling automation. The robotics research is being done to enhance sterile manufacturing to keep up with supply demand. The technology will support the Nephron 503B Outsourcing Facility, a cGMP manufacturer providing sterile, prefilled medications.
The partnership is Nephron's first with the University and was developed through External Affairs' Office of Corporate Partnerships and Strategic Initiatives at Clemson. "Industry needs are changing at a rapid rate, and Clemson is equipped to support companies like Nephron. Together, we have created a mutually beneficial project to enhance their capabilities while providing the University's students with unique, hands-on research experience," said Angie Leidinger, vice-president for External Affairs, in the press release.
Clemson College of Engineering, Computing, and Applied Science professor and researcher Yue "Sophie" Wang, mechanical engineering doctoral student Brandon Delspina, and mechanical engineering master's student Yu "Gloria" Zhang are performing the robotics research.
Source: Nephron
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.